<DOC>
	<DOC>NCT00654446</DOC>
	<brief_summary>The purpose of this study is to assess the effects on the kidney of rosuvastatin and simvastatin in subjects with Fredrickson Type IIa &amp; Type IIb Dyslipidaemia</brief_summary>
	<brief_title>IIIb 6 Week Open Label Multicentre Rosuvastatin &amp; Simvastatin</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Lipid Regulating Agents</mesh_term>
	<criteria>Fasting low density lipoprotein level as defined by the protocol. Fasting triglyceride level as defined by the protocol. The use of lipid lowering drugs or dietary supplements after Visit 1. Active arterial disease eg Unstable angina, or recent arterial surgery Blood creatine levels above the limits defined in the protocol or +4 proteinuria during dietary lead in period. Uncontrolled hypertension, hypothyroidism, alcohol or drug abuse.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Cholesterol</keyword>
	<keyword>low density lipoproteins</keyword>
	<keyword>dyslipidaemia</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Crestor</keyword>
	<keyword>Simvastatin</keyword>
	<keyword>Zocor</keyword>
	<keyword>Renal</keyword>
	<keyword>kidney</keyword>
</DOC>